Related Experiment Video

Updated: Jun 9, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

The toxic effects of α-hemolysin and β-hemolysin produced by Staphylococcus aureus

Qiuyu Zhang1, Yu Wu1, Dan Luo1

  • 1Medical Laboratory Center, Pu'er People's Hospital, Pu'er, China.

Frontiers in Immunology
|June 8, 2026
PubMed

Insights

Staphylococcus aureus infections are difficult to treat due to rising drug resistance. This review details the toxic effects of alpha and beta hemolysins, key S. aureus toxins, to guide antitoxin development.

Area of Science:

  • Microbiology
  • Toxicology
  • Infectious Diseases

Background:

  • Staphylococcus aureus (S. aureus) is a common Gram-positive bacterium causing various infections.
  • Drug-resistant strains like Methicillin-resistant S. aureus (MRSA) and Vancomycin-resistant S. aureus (VRSA) pose significant clinical challenges.
  • No effective vaccine currently exists for S. aureus infections.

Purpose of the Study:

  • To summarize the toxic effects of alpha hemolysin and beta hemolysin produced by S. aureus.
  • To enhance understanding of the roles these toxins play in S. aureus infection processes.
  • To provide a reference for developing antitoxin therapies against S. aureus.

Main Methods:

  • Literature review of studies on S. aureus virulence factors.
  • Analysis of research detailing the mechanisms of alpha and beta hemolysin toxicity.
  • Synthesis of information on the contribution of these toxins to S. aureus pathogenesis.

Main Results:

  • Alpha hemolysin and beta hemolysin are critical virulence factors contributing to S. aureus pathogenicity.
  • These toxins exhibit diverse toxic effects, impacting host tissues and immune responses.
  • Understanding their specific roles is crucial for targeted therapeutic strategies.

Conclusions:

  • Alpha and beta hemolysins are key targets for developing novel S. aureus treatments.
  • Further research into antitoxin therapies based on these toxins shows promise.
  • Elucidating toxin functions aids in combating challenging S. aureus infections.
Keywords:
Staphylococcus aureuscell deathinflammatory regulationα hemolysinβ hemolysin

More Related Videos

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source06:37

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source

Published on: February 7, 2013

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...